Imogen Bell blogs about a recent randomised controlled trial of the SlowMo app, which aimed to slow down thinking patterns and correct interpretation biases in people experiencing paranoia.
[read the full story...]Psychotherapy for depression across different age groups
David Hallford summarises a recent systematic review and meta-analysis on the effectiveness of psychotherapy for depression across the lifespan.
[read the full story...]CBT delivery formats for adult depression: group, telephone & guided self-help all as effective as individual therapy?
Kinga Antal reviews a network meta-analysis which finds that individual, group, telephone and guided self-help CBT are all equally effective for treating depression in adults.
[read the full story...]CBT for health anxiety: should it be delivered in person or online?
Francesca Bentivegna explores a timely RCT concluding that delivering internet-based (email) CBT for health anxiety is non-inferior to face to face CBT in the short-term. The study also concludes that iCBT is more cost-effective.
[read the full story...]In harm’s way: psychiatric diagnosis and risks of being subjected to and perpetrating violence
Sarah Steeg discusses a cohort study finding that people with a psychiatric diagnosis are 3-4 times more likely to be a victim or perpetrator of violence.
[read the full story...]Are antidepressants safe? A new umbrella review of observational studies suggests they are, but we need more accurate data
Andrea Cipriani and Anneka Tomlinson scrutinise a brand new umbrella review of the associations between antidepressants and adverse health outcomes, which suggests that antidepressants are safe for most people who experience mental health difficulties.
[read the full story...]What causes Autistic Spectrum Disorder?
Ben Janaway explores a recent review in JAMA Psychiatry on the emerging clinical neuroscience of Autism Spectrum Disorder.
[read the full story...]Intranasal esketamine for treatment-resistant depression: the first clinical study
Jodi Rintelman writes her debut elf blog on the first randomised controlled trial on the efficacy and safety of intranasal esketamine as an adjunctive treatment to antidepressants for treatment-resistant depression.
[read the full story...]Who gets bullied? Using genetic information to identify individual vulnerabilities
Lucy Bowes explores a multi-polygenic score approach to identifying individual vulnerabilities associated with the risk of bullying, which suggests that depression, ADHD, risk taking, BMI and intelligence are independently associated with exposure to bullying.
[read the full story...]Genetic predictors of depression trajectories in adolescence
Megan Skelton explores a study that uses polygenic scores in the context of longitudinal developmental data, to characterise developmental trajectories and the role of neuropsychiatric genetic risk variants in early-onset depression.
[read the full story...]